News-Medical.Net November 11, 2024
Vijay Kumar Malesu

By integrating DNA sequence and epigenetic context, CpGPT sets new standards for predicting aging-related outcomes, offering unprecedented accuracy in assessing mortality and disease risk across various datasets.

*Important notice: bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

In a recent pre-print* study posted to the bioRxiv server, a team of researchers introduced the Cytosine-phosphate-Guanine Pretrained Transformer (CpGPT: a transformer-based foundation model for deoxyribonucleic acid (DNA) methylation) designed to enhance analysis and prediction across diverse tissues and conditions.

Background

Since the advent of transformer architecture, artificial intelligence has rapidly progressed, especially through foundation models and large language models (LLMs) that utilize self-attention to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Technology
OpenAI Roundup: Happenings In The End Of An AI Year
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Healthcare providers will need to boost cyber defenses amid AI adoption: Moody’s
Breaking Through The Generative AI Memory Wall
Google Cloud launches AI Agent Space amid rising competition

Share This Article